Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate for sedation in elderly colonoscopy
NCT05255211Phase 4Recruiting
- Sponsor
- Renji Hospital
- Start
- Dec 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of remimazolam, sponsored by Renji Hospital. Primary endpoint: Mini-mental State Examination. Started Dec 2021; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05255211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05255211.